The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of pre-treatment magnetic resonance imaging (MRI) radiomic analysis in patients with squamous cell carcinoma of the head and neck (SCCHN).
 
Salvatore Alfieri
No Relationships to Disclose
 
Rebecca Romanò
No Relationships to Disclose
 
Marco Bologna
No Relationships to Disclose
 
Giuseppina Calareso
No Relationships to Disclose
 
Aurora Mirabile
No Relationships to Disclose
 
Andrea Ferri
No Relationships to Disclose
 
Alessandra Marcantoni
No Relationships to Disclose
 
Enrica Grosso
No Relationships to Disclose
 
Achille Tarsitano
No Relationships to Disclose
 
Sara Valerini
No Relationships to Disclose
 
Stefania Vecchio
No Relationships to Disclose
 
Letizia Deantonio
No Relationships to Disclose
 
Fulvia Blengio
No Relationships to Disclose
 
Toni Ibrahim
Consulting or Advisory Role - Eisai; Novartis (Inst); Sanofi
Travel, Accommodations, Expenses - Ipsen; Novartis; Pharmamar
 
Moela Mancinelli
No Relationships to Disclose
 
Francesco Ascoli
No Relationships to Disclose
 
Paolo Bossi
Honoraria - Bristol-Myers Squibb; Kyowa Hakko Kirin; Merck
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Sanofi/Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Helsinn Therapeutics (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Laura Deborah Locati
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; McCann Health; Merck Serono; MSD
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Ipsen; Merck Serono; MSD
 
Luca Mainardi
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen and Nanobiotics Sa; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Doxapharma; Eisai; GlaxoSmithKline; Incyte; Merck Serono; MSD; Nanobiotix; Novartis; Roche; SOBI
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Merck Serono; MSD